LD-2 disclosure · 2nd Quarter - Report
SEKRIS CORPORATION
Income$10Kfee reported
Client
- Description
- Development of vaccines for the treatment of Immune-Mediated Inflammatory Disorders
- Location
- California · United States of America
Registrant
- Description
- government relations
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
3 issuesHealth Issues
No lobbying activity this quarter.
LobbyistsLETITIA WHITE · mr DAVID FREDERICK KILIAN · AMANDA KING
TargetedHOUSE OF REPRESENTATIVES
Budget/Appropriations
HR ____, Department of Defense Appropriation Act, 2011, Title IV, all provisions relating to development of vaccines.
LobbyistsLETITIA WHITE · mr DAVID FREDERICK KILIAN · AMANDA KING
TargetedHOUSE OF REPRESENTATIVES
Defense
HR 5136 / S 3454, National Defense Authorization Act, 2011, Title II, all provisions relating to development of vaccines.
LobbyistsLETITIA WHITE · mr DAVID FREDERICK KILIAN · AMANDA KING
TargetedHOUSE OF REPRESENTATIVES